威尔药业：舜泰宗华拟减持不超0.33%股份

Core Viewpoint - Weir Pharmaceuticals (603351.SH) announced that Shuntai Zonghua plans to reduce its shareholding by a maximum of 446,300 shares, which accounts for 0.33% of the company's total share capital, through centralized bidding from March 23 to April 10, 2026 [1] Summary by Category - Company Actions - Shuntai Zonghua intends to reduce its stake in Weir Pharmaceuticals by up to 446,300 shares [1] - The reduction represents 0.33% of the total share capital of the company [1] - Timeline - The share reduction is scheduled to take place between March 23 and April 10, 2026 [1]